Related Experiment Video
Updated: Aug 29, 2026
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas
V Thorns1, G F Walter, C Thorns
1Institute of Neuropathology, Medical School of Hannover, Carl-Neuberg-Str. 1, 30625 Hannover, Germany. Thorns.veronika@mh-hannover.de
Abstract:
The members of the matrix metalloproteinase family (MMP) have the ability to degrade macromolecules of the extracellular matrix and are responsible for tumor invasion and infiltration, limiting the effectiveness of the neurosurgical resection of brain tumors. Among the glial brain tumors, astrocytomas and oligodendrogliomas are the most important tumor entities and require a different therapeutic approach. To determine the pattern of MMP expression in astrocytic and oligodendroglial tumors, sections of astrocytic and oligodendroglial differentiated glioblastomas (WHO grade IV), as well as of anaplastic oligodendrogliomas (WHO grade III) and anaplastic gemistocytic astrocytomas (WHO grade III) were immunostained for MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11. MMP-7, MMP-10 and MMP-11 were strongly expressed by neoplastic gemistocytic astrocytes while oligodendrocytic tumor regions showed only a low immunoreaction. In contrast, MMP-2 and MMP-9 mainly immunolabeled vascular structures. These data indicated that MMP-7, MMP-10 and MMP-11 contribute to the worse prognosis of astrocytic tumors when compared to oligodendrogliomas, while MMP-2 and MMP-9 might play an important role in neo-angiogenesis and tumor vascularization.
Insights
Matrix metalloproteinases (MMPs) influence brain tumor invasion. MMP-7, MMP-10, and MMP-11 are highly expressed in astrocytomas, correlating with poorer prognosis, unlike oligodendrogliomas. MMP-2 and MMP-9 are linked to tumor vascularization.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cancer Research
Background:
- Matrix metalloproteinases (MMPs) degrade extracellular matrix, facilitating tumor invasion and infiltration, which hinders neurosurgical resection of brain tumors.
- Astrocytomas and oligodendrogliomas are key glial brain tumors with distinct therapeutic requirements.
- Understanding MMP expression patterns is crucial for differentiating tumor behavior and prognosis.
Purpose of the Study:
- To investigate the expression patterns of specific matrix metalloproteinases (MMPs) in astrocytic and oligodendroglial brain tumors.
- To correlate MMP expression with tumor type (astrocytoma vs. oligodendroglioma) and grade.
- To elucidate the potential roles of different MMPs in tumor invasion, prognosis, and vascularization.
Main Methods:
- Immunohistochemical staining of tumor sections from glioblastomas (WHO grade IV), anaplastic oligodendrogliomas (WHO grade III), and anaplastic gemistocytic astrocytomas (WHO grade III).
- Analysis of MMP-2, MMP-7, MMP-9, MMP-10, and MMP-11 expression in neoplastic cells and vascular structures.
- Comparative analysis of MMP expression between astrocytic and oligodendroglial tumor components.
Main Results:
- MMP-7, MMP-10, and MMP-11 showed strong expression in neoplastic gemistocytic astrocytes (astrocytic tumors).
- Oligodendroglial tumor regions exhibited low immunoreaction for MMP-7, MMP-10, and MMP-11.
- MMP-2 and MMP-9 primarily labeled vascular structures in both tumor types, suggesting a role in neo-angiogenesis.
Conclusions:
- Differential expression of MMP-7, MMP-10, and MMP-11 in astrocytic tumors compared to oligodendroglial tumors may contribute to the worse prognosis observed in astrocytic gliomas.
- MMP-2 and MMP-9 likely play significant roles in the neo-angiogenesis and vascularization of brain tumors.
- Targeting specific MMPs could offer novel therapeutic strategies for managing brain tumors based on their molecular profiles.
